Commercial law firm Hill Dickinson’s private equity team has advised Helios Global Group on its acquisition of Cambridge-based Cogentia, a health economics and outcomes research (HEOR) and market access consultancy.
Helios, a full-service healthcare communications group working with some of the world’s leading pharmaceutical and biotech clients, is backed by the Manchester-based private equity firm, NorthEdge.
The acquisition will strengthen the group’s service offering to the life sciences sector and will enable Helios to further expand its specialist services for clients and increase its global talent base.
Hill Dickinson’s head of private equity, David Mkhitarian, and senior associate Katy Oakes advised Helios on the transaction, with support from Tasha Millar and Nazmin Choudhury and Paula Mas Alvarez.
Commenting on the deal, David Mkhitarian said: “The opportunity for Helios to acquire a UK business whose specialism in HEOR and market access complements its own ambitions and extends its global capabilities made sound commercial sense. Ongoing financial backing from NorthEdge has enabled this to happen and we are pleased to have provided legal advice to the team at Helios throughout the process.”
Since NorthEdge first invested in Helios in 2021, the company has more than doubled its revenues, grown its headcount from 100 to 250 and expanded its global operations across Manchester, Oxford, and Connecticut in the USA.
Cogentia is recognised as one of the UK’s leading market access consultancies, handling projects across numerous therapeutic areas in markets throughout the world. It undertakes research and data-led health analysis for a range of global pharmaceutical and healthcare companies, supporting them in getting their products to market and ensuring patient uptake.
